Category
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Today's News
More News
Stem Cell Therapy Could Be Breakthrough Against Type 1 Diabetes

Stem Cell Therapy Could Be Breakthrough Against Type 1 Diabetes

By Denise Mann HealthDay ReporterWEDNESDAY, Oct. 4, 2023 (HealthDay News) -- People with type 1 diabetes lack functional islet cells in their pancreas to produce the hormone insulin and must take dail

Stem Cell Therapy Could Be Breakthrough Against Type 1 Diabetes

By Denise Mann HealthDay ReporterWEDNESDAY, Oct. 4, 2023 (HealthDay News) -- People with type 1 diabetes lack functional islet cells in their pancreas to produce the hormone insulin and must take dail
Stem Cell Therapy May Slow MS Better Than Meds: Study

Stem Cell Therapy May Slow MS Better Than Meds: Study

By Amy Norton HealthDay ReporterWEDNESDAY, Dec. 28, 2022 (HealthDay News) -- A new study is adding to evidence that people with multiple sclerosis can benefit from a type of stem cell transplant -- in

Stem Cell Therapy May Slow MS Better Than Meds: Study

By Amy Norton HealthDay ReporterWEDNESDAY, Dec. 28, 2022 (HealthDay News) -- A new study is adding to evidence that people with multiple sclerosis can benefit from a type of stem cell transplant -- in
Stem Cell ‘Junk Yards’ Reveal a New Clue About Aging

Stem Cell ‘Junk Yards’ Reveal a New Clue About Aging

New research shows that the cells’ garbage-clearing function deteriorates with age—and opens the door to reversing the process.PHOTOGRAPH: MARIYA BORISOVA/GETTY IMAGESROBERT SIGNER SEEShimself a

Stem Cell ‘Junk Yards’ Reveal a New Clue About Aging

New research shows that the cells’ garbage-clearing function deteriorates with age—and opens the door to reversing the process.PHOTOGRAPH: MARIYA BORISOVA/GETTY IMAGESROBERT SIGNER SEEShimself a
Brain 'Organoid' Study Hints at the Origins of Autism

Brain 'Organoid' Study Hints at the Origins of Autism

By Cara MurezHealthDay ReporterFRIDAY, Aug. 11, 2023 (HealthDay News) -- Research using three-dimensional replicas of the developing brain created in a lab dish is shedding new light on autism spectru

Brain 'Organoid' Study Hints at the Origins of Autism

By Cara MurezHealthDay ReporterFRIDAY, Aug. 11, 2023 (HealthDay News) -- Research using three-dimensional replicas of the developing brain created in a lab dish is shedding new light on autism spectru
Blinded by Chemical Burns, Patients Regained Sight With New Stem Cell Therapy

Blinded by Chemical Burns, Patients Regained Sight With New Stem Cell Therapy

By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 18, 2023 (HealthDay News) -- Phillip Durst was working near an industrial dishwasher when something went awry, and the machinery spewed caustic chemic

Blinded by Chemical Burns, Patients Regained Sight With New Stem Cell Therapy

By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 18, 2023 (HealthDay News) -- Phillip Durst was working near an industrial dishwasher when something went awry, and the machinery spewed caustic chemic
MDNA11 Generates Activity, Safety in Advanced Solid Tumors

MDNA11 Generates Activity, Safety in Advanced Solid Tumors

August 9, 2023Chris RyanTreatment with the long-acting interleukin-2 superkine led to durable tumor control and no dose-limiting toxicities in patients with advanced solid tumors, according to data fr

MDNA11 Generates Activity, Safety in Advanced Solid Tumors

August 9, 2023Chris RyanTreatment with the long-acting interleukin-2 superkine led to durable tumor control and no dose-limiting toxicities in patients with advanced solid tumors, according to data fr
Prexigebersen–Based Therapy Induces High CR/CRi Rates in Newly Diagnosed, Relapsed/Refractory AML

Prexigebersen–Based Therapy Induces High CR/CRi Rates in Newly Diagnosed, Relapsed/Refractory AML

August 1, 2023Caroline SeymourPrexigebersen in combination with decitabine and venetoclax demonstrated potent antitumor activity when used in the treatment of patients with newly diagnosed and relapse

Prexigebersen–Based Therapy Induces High CR/CRi Rates in Newly Diagnosed, Relapsed/Refractory AML

August 1, 2023Caroline SeymourPrexigebersen in combination with decitabine and venetoclax demonstrated potent antitumor activity when used in the treatment of patients with newly diagnosed and relapse
Frontline Immunotherapy, Delayed Nephrectomy May Allow for Improved Disease Control in mRCC

Frontline Immunotherapy, Delayed Nephrectomy May Allow for Improved Disease Control in mRCC

July 14, 2023Caroline SeymourNeoadjuvant immunotherapy–based combinations led to reductions in tumor size and pathologic necrosis at the time of cytoreductive nephrectomy in patients with metastatic r

Frontline Immunotherapy, Delayed Nephrectomy May Allow for Improved Disease Control in mRCC

July 14, 2023Caroline SeymourNeoadjuvant immunotherapy–based combinations led to reductions in tumor size and pathologic necrosis at the time of cytoreductive nephrectomy in patients with metastatic r
Daratumumab Plus Induction Therapy Reduces Stem Cell Yield in Multiple Myeloma

Daratumumab Plus Induction Therapy Reduces Stem Cell Yield in Multiple Myeloma

June 9, 2023Tony Berberabe, MPHThe addition of daratumumab to frontline induction therapy prior to peripheral blood stem cell collection reduced the number of patients with newly diagnosed multiple my

Daratumumab Plus Induction Therapy Reduces Stem Cell Yield in Multiple Myeloma

June 9, 2023Tony Berberabe, MPHThe addition of daratumumab to frontline induction therapy prior to peripheral blood stem cell collection reduced the number of patients with newly diagnosed multiple my
IBI322 Shows Early Antitumor Efficacy in PD-1/PD-L1–Resistant Classical Hodgkin Lymphoma

IBI322 Shows Early Antitumor Efficacy in PD-1/PD-L1–Resistant Classical Hodgkin Lymphoma

August 13, 2023Kristi RosaSingle-agent IBI322 elicited responses with favorable safety in patients with classical Hodgkin lymphoma that had become resistant to anti–PD-1/PD-L1 therapy, according to da

IBI322 Shows Early Antitumor Efficacy in PD-1/PD-L1–Resistant Classical Hodgkin Lymphoma

August 13, 2023Kristi RosaSingle-agent IBI322 elicited responses with favorable safety in patients with classical Hodgkin lymphoma that had become resistant to anti–PD-1/PD-L1 therapy, according to da
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...